https://medicaex.com/prnewswire/malaysian-society-of-plastic-and-reconstructive-surgery-to-host-extensive-networking-and-learning-event-for-plastic-surgeons-and-residents/ 2023-01-27T02:12:13+00:00 https://medicaex.com/prnewswire/fosun-internationals-2021-annual-report-wins-gold-award-at-the-2022-international-arc-awards/ 2023-01-27T02:12:08+00:00 https://medicaex.com/prnewswire/relive-biotechnologies-ltd-completes-asset-purchase-of-co-don-ag-and-series-a-financing-led-by-shc-furthering-its-ambition-to-become-the-global-leader-in-regenerative-therapies-2/ 2023-01-27T00:12:13+00:00 https://medicaex.com/prnewswire/intron-has-confirmed-the-efficacy-of-bal200-a-novel-endolysin-biologic-for-inhalational-anthrax/ 2023-01-27T00:12:13+00:00 https://medicaex.com/prnewswire/hbm-alpha-therapeutics-raises-seed-round-to-advance-next-gen-therapies-for-endocrine-disorders/ 2023-01-27T00:12:13+00:00 https://medicaex.com/prnewswire/rainwater-charitable-foundation-announces-fourth-annual-rainwater-prize-winners-for-brain-research/ 2023-01-26T15:12:14+00:00 https://medicaex.com/prnewswire/daewoong-pharmaceutical-submitted-nda-for-its-global-new-drug-fexuclue-in-11-countries-only-1-year-after-approval-in-korea/ 2023-01-26T14:12:15+00:00 https://medicaex.com/prnewswire/ascletis-announces-ind-approval-of-oral-viral-polymerase-inhibitor-asc10-for-monkeypox-indication-by-china-nmpa/ 2023-01-26T14:12:14+00:00 https://medicaex.com/prnewswire/genkore-announces-collaboration-with-a-us-based-company-on-in-vivo-gene-editing-therapy/ 2023-01-26T13:12:16+00:00 https://medicaex.com/prnewswire/relive-biotechnologies-ltd-completes-asset-purchase-of-co-don-ag-and-series-a-financing-led-by-shc-furthering-its-ambition-to-become-the-global-leader-in-regenerative-therapies/ 2023-01-26T12:12:16+00:00 https://medicaex.com/prnewswire/longevity-biomedical-inc-and-denali-capital-acquisition-corp-announce-business-combination-to-create-nasdaq-listed-biopharmaceutical-company-focused-on-advancing-new-technologies-to-promote-human-h/ 2023-01-26T12:12:11+00:00 https://medicaex.com/prnewswire/optimum-nutrition-believes-theres-more-of-you-in-you/ 2023-01-26T12:12:11+00:00 https://medicaex.com/prnewswire/hybribio-returns-to-medlab-middle-east-2023/ 2023-01-26T11:12:20+00:00 https://medicaex.com/prnewswire/novarad-provides-free-digital-health-record-sharing-technology-to-hospitals-in-developing-countries/ 2023-01-26T09:12:18+00:00 https://medicaex.com/prnewswire/correction-health-in-transportation-releases-new-smartphone-face-scanning-application-aimed-at-uncovering-potentially-serious-health-concerns-in-professional-drivers/ 2023-01-26T09:12:14+00:00 https://medicaex.com/prnewswire/fosun-international-wins-platinum-award-at-the-asset-esg-corporate-awards-2022/ 2023-01-26T08:12:13+00:00 https://medicaex.com/prnewswire/co-don-finally-saved-investor-has-taken-over-the-business-operations-of-the-leipzig-based-biopharmacy-company-with-an-additional-location-in-teltow-brandenburg/ 2023-01-26T06:12:13+00:00 https://medicaex.com/prnewswire/plumcare-rwe-partners-with-lifebit-on-greeces-newborn-genomic-sequencing-program-beginngs/ 2023-01-26T04:12:16+00:00 https://medicaex.com/prnewswire/singleron-launches-single-cell-eqtl-analysis-as-part-of-their-sequencing-service/ 2023-01-26T02:12:13+00:00 https://medicaex.com/prnewswire/metabolon-secures-25-million-of-funding-to-accelerate-growth/ 2023-01-26T01:12:13+00:00 https://medicaex.com/prnewswire/suvoda-2022-clinical-trials-surge-20-as-it-expands-offerings-to-include-econsent-and-ecoa/ 2023-01-26T00:12:21+00:00 https://medicaex.com/prnewswire/tradeup-acquisition-corp-announces-extension-of-the-deadline-for-an-initial-business-combination/ 2023-01-26T00:12:15+00:00 https://medicaex.com/prnewswire/international-symposium-at-the-vatican-on-hansens-disease-to-focus-on-theme-of-leave-no-one-behind/ 2023-01-25T21:12:14+00:00 https://medicaex.com/prnewswire/health-in-transportation-nuralogix-release-new-smartphone-face-scanning-application-aimed-at-uncovering-life-threatening-health-concerns-in-professional-drivers/ 2023-01-25T20:12:19+00:00 https://medicaex.com/prnewswire/sk-bioscience-appoints-new-executives-to-accelerate-new-growth-strategies/ 2023-01-25T20:12:15+00:00 https://medicaex.com/prnewswire/a-healthy-winter-action-second-batch-of-19600-bottles-of-azvudine-delivered-to-24-counties/ 2023-01-25T17:12:15+00:00 https://medicaex.com/prnewswire/dualitybio-announces-db-1303-granted-fast-track-designation-by-the-u-s-food-and-drug-administration-fda-for-the-treatment-of-advanced-recurrent-or-metastatic-endometrial-carcinoma-with-her2-overex/ 2023-01-25T15:12:16+00:00 https://medicaex.com/prnewswire/debiopharm-applies-extended-release-formulation-expertise-to-reduce-treatment-frequency-burden-for-acromegaly-gep-net-patients-2/ 2023-01-25T00:12:16+00:00 https://medicaex.com/prnewswire/amcor-to-report-half-year-2023-results/ 2023-01-24T23:12:09+00:00 https://medicaex.com/prnewswire/412-5-million-mabwell-announces-exclusive-licensing-agreement-with-disc-medicine-inc-for-innovative-drug-candidates-of-hematologic-diseases/ 2023-01-24T13:12:16+00:00 https://medicaex.com/prnewswire/complete-genomics-to-announce-new-product-launches-at-agbt-general-meeting/ 2023-01-24T13:12:10+00:00 https://medicaex.com/prnewswire/strava-acquires-outdoor-adventure-platform-fatmap/ 2023-01-24T12:12:10+00:00 https://medicaex.com/prnewswire/2023-japan-prize-laureates-announced/ 2023-01-24T07:12:09+00:00 https://medicaex.com/prnewswire/acceptance-period-for-exchange-offer-extended-pending-competition-clearances/ 2023-01-23T07:12:09+00:00 https://medicaex.com/prnewswire/accuray-announces-first-patient-treatments-in-new-zealand-with-the-cyberknife-system-the-worlds-only-robotic-radiation-therapy-delivery-device/ 2023-01-22T21:12:18+00:00 https://medicaex.com/prnewswire/biomerics-completes-connecticut-expansion/ 2023-01-20T15:12:09+00:00 https://medicaex.com/prnewswire/china-jo-jo-drugstores-announces-2-625-million-registered-direct-offering/ 2023-01-20T14:12:10+00:00 https://medicaex.com/prnewswire/intron-is-finalizing-the-sal200-tech-transfer/ 2023-01-20T13:12:28+00:00 https://medicaex.com/prnewswire/sun-pharma-to-acquire-concert-pharmaceuticals-advancing-the-potential-treatment-of-alopecia-areata/ 2023-01-20T13:12:19+00:00 https://medicaex.com/prnewswire/revitalize-beauty-through-science-skincare-tech-brand-amiro-unveils-its-all-in-one-led-light-therapy-face-mask/ 2023-01-20T13:12:10+00:00 https://medicaex.com/prnewswire/zhongchao-inc-launches-medication-management-assistance-mini-program-to-facilitate-cancer-treatment/ 2023-01-20T10:12:14+00:00 https://medicaex.com/prnewswire/cnns-vital-signs-explores-the-potential-of-medical-non-invasive-therapeutic-technology/ 2023-01-20T08:12:15+00:00 https://medicaex.com/prnewswire/global-times-spring-festival-hustle-and-bustle-back-heralds-vibrant-year-ahead/ 2023-01-20T06:12:13+00:00 https://medicaex.com/prnewswire/medalliance-selution-slr-is-the-first-deb-to-receive-coronary-de-novo-ide-approval-its-fourth-fda-ide-deb-approval/ 2023-01-20T05:12:21+00:00 https://medicaex.com/prnewswire/chinas-first-and-only-approved-third-generation-bcr-abl-inhibitor-olverembatinib-included-into-the-2022-national-reimbursement-drug-list/ 2023-01-20T05:12:14+00:00 https://medicaex.com/prnewswire/vista-eye-specialist-to-host-eye-health-carnival-nationwide-in-malaysia/ 2023-01-20T01:12:15+00:00 https://medicaex.com/prnewswire/innovent-announces-inclusion-in-the-china-national-reimbursement-drug-list-nrdl-of-tyvyt-in-two-new-indications-olverembatinib-for-the-first-listing-byvasda-halpryza-and-sulinno-in-multiple-new-i/ 2023-01-20T00:12:14+00:00 https://medicaex.com/prnewswire/youtheory-collagen-liquid-expands-beauty-on-the-go-product-in-japan/ 2023-01-19T23:12:08+00:00 https://medicaex.com/prnewswire/renexxion-announces-opening-of-investigational-new-drug-ind-application-for-naronapride-for-the-treatment-of-gastrointestinal-dysmotility-in-cystic-fibrosis-patients/ 2023-01-19T18:12:20+00:00 https://medicaex.com/prnewswire/seragon-announces-restorin-the-most-advanced-anti-aging-nutraceutical-to-date/ 2023-01-19T16:12:15+00:00 https://medicaex.com/prnewswire/cambrex-completes-acquisition-of-snapdragon-chemistry-a-leader-in-continuous-flow-api-development-services/ 2023-01-19T15:12:15+00:00 https://medicaex.com/prnewswire/health-in-tech-partners-with-6-degree-health-and-90-degree-benefits-to-form-a-new-value-based-level-funded-health-plan/ 2023-01-19T14:12:09+00:00 https://medicaex.com/prnewswire/agilis-roboticstm-completes-new-round-of-live-animal-trials-with-miniaturized-robotic-instruments-for-endoscopic-surgery/ 2023-01-19T10:12:18+00:00 https://medicaex.com/prnewswire/wfh-gene-therapy-registry-now-live/ 2023-01-19T10:12:14+00:00 https://medicaex.com/prnewswire/medtech-innovator-magassist-inc-gains-recognition-for-its-innovation-in-the-cardiovascular-field-at-2022-critical-heart-disease-congress-international-society-for-mechanical-circulatory-support-paral/ 2023-01-19T07:12:20+00:00 https://medicaex.com/prnewswire/docquity-delivers-10-market-share-growth-for-philippine-based-pharmaceutical-client-in-just-one-year/ 2023-01-19T07:12:15+00:00 https://medicaex.com/prnewswire/pulnovo-medical-announces-dr-mingdong-zhang-former-fda-medical-device-officer-joins-scientific-advisory-board-2/ 2023-01-19T00:12:18+00:00 https://medicaex.com/prnewswire/everise-repositions-branding-to-cement-evolution-as-end-to-end-customer-service-player/ 2023-01-18T15:12:09+00:00 https://medicaex.com/prnewswire/netapp-applauded-by-frost-sullivan-for-addressing-complex-and-constantly-evolving-healthcare-and-life-sciences-challenges-with-its-cloud-services/ 2023-01-18T14:12:12+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-launches-ath434-phase-2-clinical-trial-in-the-united-states-for-the-treatment-of-individuals-with-multiple-system-atrophy/ 2023-01-18T13:12:21+00:00 https://medicaex.com/prnewswire/meihua-international-medical-technologies-co-ltd-enters-into-strategic-partnership-with-getein-biotech-inc-to-jointly-produce-and-sell-covid-19-antigen-test-kits-and-ivds/ 2023-01-18T13:12:19+00:00 https://medicaex.com/prnewswire/iaso-bio-announces-u-s-fda-approval-of-clinical-trial-application-for-bcma-car-t-ct103a-for-relapsed-refractory-multiple-myeloma/ 2023-01-18T13:12:16+00:00 https://medicaex.com/prnewswire/boehringer-ingelheim-malaysia-honored-as-top-employer-for-the-fifth-consecutive-year/ 2023-01-18T13:12:15+00:00 https://medicaex.com/prnewswire/iaso-bio-raises-nearly-75-million-in-series-c1-funding/ 2023-01-18T13:12:15+00:00 https://medicaex.com/prnewswire/transcenta-to-present-trial-in-progress-at-asco-gi-2023-for-tst001-osemitamab-combination-with-nivolumab-with-or-without-chemotherapy-in-advanced-g-gej-cancer/ 2023-01-18T11:12:15+00:00 https://medicaex.com/prnewswire/immorna-receives-ind-clearance-to-conduct-a-phase-1-study-of-jcxh-105-a-self-replicating-rna-based-shingles-vaccine/ 2023-01-18T10:12:21+00:00 https://medicaex.com/prnewswire/fapon-to-attend-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-18T10:12:18+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-top-line-data-from-phase-i-study-of-ever206-on-healthy-subjects-in-china/ 2023-01-18T10:12:14+00:00 https://medicaex.com/prnewswire/asieris-appoints-dr-linda-wu-as-chief-development-officer/ 2023-01-18T10:12:14+00:00 https://medicaex.com/prnewswire/abbisko-therapeutics-obtains-approval-from-the-china-nmpa-to-conduct-a-phase-ii-clinical-study-of-pimicotinib-absk021%ef%bc%89-in-cgvhd/ 2023-01-18T10:12:14+00:00 https://medicaex.com/prnewswire/cigna-wins-vhis-medical-insurance-and-high-end-medical-insurance-awards-at-the-10life-5-star-insurance-award-2022/ 2023-01-18T06:12:08+00:00 https://medicaex.com/prnewswire/mental-health-focus-makes-boehringer-ingelheim-stand-out-as-top-employer-2023-in-asia-pacific-for-third-consecutive-year/ 2023-01-18T02:12:15+00:00 https://medicaex.com/prnewswire/boehringer-ingelheim-indonesia-honored-as-top-employer-for-the-fourth-consecutive-year/ 2023-01-18T02:12:09+00:00 https://medicaex.com/prnewswire/jacobio-completes-first-patient-dosage-of-aurora-a-inhibitor-jab-2485-in-u-s/ 2023-01-18T01:12:22+00:00 https://medicaex.com/prnewswire/tanso-biosciences-expands-its-line-up-with-250-mouse-gpcrs/ 2023-01-18T01:12:15+00:00 https://medicaex.com/prnewswire/telix-reports-fourth-quarter-2022-financial-results/ 2023-01-18T01:12:14+00:00 https://medicaex.com/prnewswire/lepure-biotech-closes-series-c-financing-co-led-by-novo-holdings-general-atlantic-and-goldman-sachs-asset-management/ 2023-01-18T00:12:15+00:00 https://medicaex.com/prnewswire/metabolon-expands-inflammation-portfolio-with-targeted-panels-for-cannabinoids-sphingolipids-and-lipid-mediators-of-inflammation/ 2023-01-18T00:12:15+00:00 https://medicaex.com/prnewswire/ocedurenone-kbp-5074-featured-at-asn-kidney-week-ocedurenone-is-a-potential-new-treatment-option-for-patients-with-uncontrolled-or-resistant-hypertension-and-advanced-ckd/ 2023-01-17T23:12:20+00:00 https://medicaex.com/prnewswire/health-supplement-information-app-pillwork-set-for-launch-in-the-first-half-year/ 2023-01-17T23:12:14+00:00 https://medicaex.com/prnewswire/organon-is-recognized-as-both-top-employers-china-2023-and-best-workplaces-in-greater-china-2022/ 2023-01-17T23:12:14+00:00 https://medicaex.com/prnewswire/full-life-technologies-announces-appointment-of-steffen-heeger-md-phd-as-chief-medical-officer-and-fa-liu-phd-as-chief-scientific-officer/ 2023-01-17T16:12:16+00:00 https://medicaex.com/prnewswire/cgtn-china-monitors-coronavirus-mutations-to-adjust-covid-19-response/ 2023-01-17T15:12:14+00:00 https://medicaex.com/prnewswire/flattech-llc-receives-innovative-technology-contract-from-vizient-for-epifaithr-syringe-for-safer-epidurals/ 2023-01-17T14:12:20+00:00 https://medicaex.com/prnewswire/earabler-disrupts-sleep-tech-with-frenztm-brainband-global-launch-event-at-ces-2023/ 2023-01-17T14:12:20+00:00 https://medicaex.com/prnewswire/lydus-medical-announces-fda-clearance-of-vesseal-the-microvascular-anastomosis-aid-device-for-small-arteries/ 2023-01-17T14:12:19+00:00 https://medicaex.com/prnewswire/fda-accepts-gmp-plasmid-dmf-of-obio-technology/ 2023-01-17T14:12:16+00:00 https://medicaex.com/prnewswire/affamed-therapeutics-to-commercialize-galcanezumab-for-migraine-prevention-in-mainland-china/ 2023-01-17T14:12:16+00:00 https://medicaex.com/prnewswire/fapon-presents-at-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-17T13:12:17+00:00 https://medicaex.com/prnewswire/carsgen-therapeutics-and-huadong-medicine-announce-collaboration-agreement-for-zevorcabtagene-autoleucel-in-mainland-china/ 2023-01-17T12:12:15+00:00 https://medicaex.com/prnewswire/henlius-novel-anti-pd-1-mab-hansizhuang-serplulimab-approved-for-the-treatment-of-es-sclc/ 2023-01-17T12:12:15+00:00 https://medicaex.com/prnewswire/thirty-years-into-the-future-infinitus-releases-its-csr-report-for-the-16th-consecutive-year/ 2023-01-17T02:12:13+00:00 https://medicaex.com/prnewswire/ascletis-announces-entering-into-a-supply-agreement-of-ritonavir-tablets-with-simcere/ 2023-01-17T01:12:15+00:00 https://medicaex.com/prnewswire/novogene-announces-deployment-of-illumina-novaseq-x-plus-and-pacbio-revio-sequencing-systems/ 2023-01-17T00:12:17+00:00 https://medicaex.com/prnewswire/tpisoftwares-ai-powered-systalk-chat-to-elevate-chang-gung-memorial-hospitals-customer-services/ 2023-01-17T00:12:14+00:00 https://medicaex.com/prnewswire/juniper-biologics-partners-with-caris-life-sciences-for-molecular-profiling-distribution-in-south-east-asia/ 2023-01-17T00:12:14+00:00 https://medicaex.com/prnewswire/sd-biosensor-successfully-finishes-jp-morgan-healthcare-conference/ 2023-01-17T00:12:13+00:00 https://medicaex.com/prnewswire/amcor-expands-healthcare-platform-in-the-asia-pacific-region-with-acquisition-of-mdk/ 2023-01-16T23:12:08+00:00 https://medicaex.com/prnewswire/debiopharm-applies-extended-release-formulation-expertise-to-reduce-treatment-frequency-burden-for-acromegaly-gep-net-patients/ 2023-01-16T10:12:15+00:00 https://medicaex.com/prnewswire/b-dot-medical-to-install-its-first-practical-ultra-compact-proton-therapy-system-at-hospital-in-tokyo/ 2023-01-16T09:12:19+00:00 https://medicaex.com/prnewswire/identity-for-all-children-and-their-brighter-future-in-an-accessible-society-for-all/ 2023-01-16T09:12:10+00:00 https://medicaex.com/prnewswire/ascletis-announces-dosing-of-4-healthy-subjects-of-the-first-cohort-in-multiple-dose-escalation-phase-i-clinical-trial-of-oral-3clpro-inhibitor-asc11-for-covid-19/ 2023-01-16T01:12:13+00:00 https://medicaex.com/prnewswire/forever-living-products-international-announces-new-president/ 2023-01-16T01:12:08+00:00 https://medicaex.com/prnewswire/cgtn-xi-jinping-salutes-ordinary-peoples-extraordinary-efforts-in-new-year-address/ 2023-01-15T23:12:12+00:00 https://medicaex.com/prnewswire/lunit-to-supply-ai-solution-for-chest-x-ray-analysis-to-albert-einstein-latin-americas-largest-hospital/ 2023-01-14T14:12:17+00:00 https://medicaex.com/prnewswire/verana-health-receives-new-product-innovation-award-from-frost-sullivan-for-its-veraq-population-health-data-engine/ 2023-01-14T14:12:14+00:00 https://medicaex.com/prnewswire/having-committed-to-growth-in-the-new-year-unicoeye-accelerates-its-online-expansion/ 2023-01-13T16:12:08+00:00 https://medicaex.com/prnewswire/tjp-labs-inc-receives-fda-acceptance-for-premarket-tobacco-product-application-pmta/ 2023-01-13T15:12:07+00:00 https://medicaex.com/prnewswire/cgtn%ef%bc%9ahow-do-emergency-wards-in-china-cope-with-increasing-covid-patients/ 2023-01-13T14:12:11+00:00 https://medicaex.com/prnewswire/bio4t2-announces-first-patient-infused-with-car-t-targeting-solid-tumors/ 2023-01-13T03:12:15+00:00 https://medicaex.com/prnewswire/accor-reveals-its-thought-leading-health-to-wealth-white-paper/ 2023-01-12T13:12:09+00:00 https://medicaex.com/prnewswire/adm-group-appoints-justin-barton-as-executive-chairman-and-ed-colflesh-as-global-ceo/ 2023-01-12T10:12:09+00:00 https://medicaex.com/prnewswire/double-blind-period-completes-primary-endpoint-analysis-of-phase-3-clinical-trial-to-be-conducted-for-chinas-first-hormone-replacement-treatment-targeting-hypoparathyroidism/ 2023-01-12T09:12:22+00:00 https://medicaex.com/prnewswire/samsung-biologics-receives-the-terra-carta-seal-in-recognition-of-the-companys-commitment-to-creating-a-sustainable-future/ 2023-01-12T09:12:15+00:00 https://medicaex.com/prnewswire/innovent-announces-first-participant-dosed-in-a-phase-3-clinical-study-dreams-2-of-mazdutide-ibi362-in-chinese-patients-with-type-2-diabetes/ 2023-01-12T05:12:15+00:00 https://medicaex.com/prnewswire/amr-action-fund-announces-investment-in-bioversys-ag/ 2023-01-12T01:12:22+00:00 https://medicaex.com/prnewswire/prenetics-owned-act-genomics-receives-fda-clearance-for-actonco-the-first-asia-based-company-to-receive-clearance-for-a-comprehensive-genomic-profiling-test-for-all-solid-tumors/ 2023-01-12T01:12:15+00:00 https://medicaex.com/prnewswire/ajinomoto-and-exelixis-enter-into-a-license-agreement-to-discover-and-develop-novel-antibody-drug-conjugates-for-the-treatment-of-cancer/ 2023-01-11T22:12:22+00:00 https://medicaex.com/prnewswire/novavax-announces-initiation-of-phase-2-trial-for-covid-19-influenza-combination-and-stand-alone-influenza-vaccine-candidates/ 2023-01-11T15:12:14+00:00 https://medicaex.com/prnewswire/bioniq-repair-toothpaste-with-20-biohap-scientifically-proven-to-remineralise-enamel-and-keeps-teeth-healthy-and-strong/ 2023-01-11T13:12:21+00:00 https://medicaex.com/prnewswire/epivax-and-zoetis-to-collaborate-on-swine-t-cell-epitope-prediction-tool-circomatch/ 2023-01-11T13:12:17+00:00 https://medicaex.com/prnewswire/china-enters-new-stage-in-covid-19-response/ 2023-01-11T10:12:13+00:00 https://medicaex.com/prnewswire/cgtn-vitality-under-covid-19-chinas-smart-ports-aid-increased-throughput/ 2023-01-11T09:12:11+00:00 https://medicaex.com/prnewswire/burning-rock-received-fda-breakthrough-device-designation-for-its-overc-multi-cancer-detection-blood-test/ 2023-01-11T01:12:17+00:00 https://medicaex.com/prnewswire/treadwell-therapeutics-announces-fast-track-designation-granted-by-the-fda-to-cfi-402257-for-the-treatment-of-er-her2-breast-cancer/ 2023-01-10T14:12:16+00:00 https://medicaex.com/prnewswire/csafe-bolsters-its-digital-ecosystem-launching-tracsafe-data-loggers-and-csafe-connect-portal/ 2023-01-10T13:12:14+00:00 https://medicaex.com/prnewswire/clarivate-identifies-fifteen-potential-blockbuster-drugs-in-annual-drugs-to-watch-report/ 2023-01-10T13:12:14+00:00 https://medicaex.com/prnewswire/sk-inc-hosts-sk-bio-night-in-san-francisco-to-expand-global-partnerships/ 2023-01-10T13:12:14+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-to-present-future-plan-for-global-investors-partners-at-sk-bio-night/ 2023-01-10T13:12:14+00:00 https://medicaex.com/prnewswire/complete-genomics-launches-full-sequencing-platforms-at-biotech-showcase-2023/ 2023-01-10T13:12:13+00:00 https://medicaex.com/prnewswire/sarah-otten-joins-medison-pharma-as-vp-gm-americas-region/ 2023-01-10T12:12:16+00:00 https://medicaex.com/prnewswire/innovent-announces-first-participant-dosed-in-a-phase-3-clinical-study-dreams-1-of-mazdutide-ibi362-in-chinese-patients-with-type-2-diabetes/ 2023-01-10T11:12:14+00:00 https://medicaex.com/prnewswire/seekin-receives-ce-ivd-mark-approval-for-pancanseek-cancer-mutation-detection-kit/ 2023-01-10T09:12:17+00:00 https://medicaex.com/prnewswire/mentice-ab-publ-receives-an-order-of-usd-540000-for-simulation-solutions-from-corewell-health-grand-rapids-michigan-usa/ 2023-01-10T08:12:20+00:00 https://medicaex.com/prnewswire/shanton-screens-first-subjects-in-phase-2b-refractory-tophaceous-gout-study-with-sap-001/ 2023-01-10T08:12:16+00:00 https://medicaex.com/prnewswire/appointment-of-dr-david-john-jeans-cbe-as-histoindexs-non-executive-chairman/ 2023-01-10T06:12:13+00:00 https://medicaex.com/prnewswire/mars-petcare-and-the-broad-institute-create-open-access-database-of-dog-and-cat-genomes-to-advance-preventive-pet-care/ 2023-01-10T05:12:13+00:00 https://medicaex.com/prnewswire/futu-partners-make-a-wish-fulfil-unique-wishes-for-four-children-living-with-critical-illnesses/ 2023-01-10T04:12:08+00:00 https://medicaex.com/prnewswire/a-korean-dtx-company-lifesemantics-to-unveil-the-redpill-breath-solution-for-pulmonary-rehabilitation-dtx-at-ces-2023/ 2023-01-10T01:12:18+00:00 https://medicaex.com/prnewswire/amplify-health-accelerates-strategy-through-the-acquisition-of-aida-technologies/ 2023-01-10T01:12:08+00:00 https://medicaex.com/prnewswire/insilico-medicine-announces-positive-topline-results-of-the-new-zealand-phase-i-trial-of-ins018_055-an-ai-designed-drug-for-an-ai-discovered-target/ 2023-01-09T22:12:17+00:00 https://medicaex.com/prnewswire/sonivie-raises-60m-in-round-c-financing-and-appoints-new-board-members/ 2023-01-09T21:12:15+00:00 https://medicaex.com/prnewswire/the-latest-global-survey-from-isaps-reports-a-significant-rise-in-aesthetic-surgery-worldwide/ 2023-01-09T17:12:21+00:00 https://medicaex.com/prnewswire/seoul-business-agency-sba-presents-tech-hub-seoul-vision-in-ces-2023-effectively-inform-the-global-stage-about-seouls-technology-and-innovation/ 2023-01-09T17:12:10+00:00 https://medicaex.com/prnewswire/luye-pharmas-innovative-anti-cancer-therapy-lurbinectedin-to-benefit-named-patients-in-hong-kong/ 2023-01-09T16:12:18+00:00 https://medicaex.com/prnewswire/fosun-pharma-and-henlius-entered-into-an-exclusive-license-agreement-for-serplulimab-in-the-us/ 2023-01-09T15:12:17+00:00 https://medicaex.com/prnewswire/gift-of-life-donor-program-nations-leader-for-15-years/ 2023-01-09T15:12:16+00:00 https://medicaex.com/prnewswire/savewo-introduces-the-only-hong-kong-made-respirator-obtaining-top-eu-and-china-certifications-enters-medical-market-with-increased-investment-and-production-capacity/ 2023-01-09T13:12:24+00:00 https://medicaex.com/prnewswire/jacobios-kras-g12c-inhibitor-jab-21822-was-granted-breakthrough-therapy-designations-by-china-cde/ 2023-01-09T13:12:21+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-announces-1-for-10-reverse-ads-split-consolidation/ 2023-01-09T13:12:19+00:00 https://medicaex.com/prnewswire/parnell-pharmaceuticals-holdings-ltd-announces-extension-of-rights-offering/ 2023-01-09T13:12:19+00:00 https://medicaex.com/prnewswire/grand-pharma-announces-successful-clinical-progress-of-its-oral-3cl-protease-inhibitor-gs221-against-covid-19/ 2023-01-09T12:12:24+00:00 https://medicaex.com/prnewswire/ces-2023-omron-healthcare-to-unveil-new-efforts-to-realize-vision-of-going-for-zero-zero-heart-attacks-and-zero-strokes/ 2023-01-09T12:12:16+00:00 https://medicaex.com/prnewswire/innovent-announces-the-national-medical-products-administration-in-china-has-accepted-and-granted-priority-review-designation-to-the-new-drug-application-for-parsaclisib-pi3k%ce%b4-inhibitor-for-the/ 2023-01-09T12:12:16+00:00 https://medicaex.com/prnewswire/kira-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-09T10:12:15+00:00 https://medicaex.com/prnewswire/ecolog-international-appoints-juan-chaparro-as-executive-director-and-chairman-of-the-board/ 2023-01-09T10:12:09+00:00 https://medicaex.com/prnewswire/global-times-three-years-hard-effort-to-fight-covid-19-worthwhile/ 2023-01-09T02:12:13+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-announces-allowance-of-new-composition-of-matter-patent-by-the-united-states-patent-and-trademark-office/ 2023-01-08T06:12:20+00:00 https://medicaex.com/prnewswire/eoflow-submits-application-to-the-u-s-fda-for-its-wearable-insulin-pump-eopatch/ 2023-01-07T00:12:16+00:00 https://medicaex.com/prnewswire/international-captive-exchange-a-health-in-tech-company-becomes-managing-general-underwriter-mgu-for-liberty-mutual-insurance-company/ 2023-01-06T14:12:06+00:00 https://medicaex.com/prnewswire/qilu-pharmaceutical-announces-progress-of-clinical-study-of-ql1706-an-innovative-bifunctional-antibody/ 2023-01-06T13:12:20+00:00 https://medicaex.com/prnewswire/premium-ski-goggles-exceed-industry-quality-standards-during-testing/ 2023-01-06T13:12:06+00:00 https://medicaex.com/prnewswire/ascentage-pharma-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-06T12:12:12+00:00 https://medicaex.com/prnewswire/duality-biologics-announces-license-agreement-of-its-next-generation-adc-platform-with-adcendo/ 2023-01-06T10:12:11+00:00 https://medicaex.com/prnewswire/pulnovo-medical-will-be-attending-jpm-healthcare-conference-2023/ 2023-01-06T06:12:17+00:00 https://medicaex.com/prnewswire/discgenics-to-present-at-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-06T06:12:13+00:00 https://medicaex.com/prnewswire/innovent-announces-nmpas-breakthrough-therapy-designation-for-ibi351-kras-g12c-inhibitor-as-monotherapy-for-previous-treated-advanced-non-small-cell-lung-cancer/ 2023-01-06T06:12:13+00:00 https://medicaex.com/prnewswire/cognos-therapeutics-inc-to-become-publicly-listed-on-nasdaq-via-business-combination-with-nocturne-acquisition-corporation/ 2023-01-06T04:12:11+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-ceo-donghoon-lee-buys-3000-shares-of-company-stock/ 2023-01-06T02:12:05+00:00 https://medicaex.com/prnewswire/waycen-the-first-medical-ai-company-to-win-4-ces-2023-innovation-awards-proved-k-medtech/ 2023-01-05T17:12:08+00:00 https://medicaex.com/prnewswire/innovent-to-present-at-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-05T15:12:14+00:00 https://medicaex.com/prnewswire/standigm-cited-as-top-10-generative-ai-based-startup-based-on-vc-investment-2019-2021-in-gartner-report/ 2023-01-05T15:12:13+00:00 https://medicaex.com/prnewswire/cgtn-vitality-under-covid-19-china-gears-up-for-medical-supplies/ 2023-01-05T15:12:10+00:00 https://medicaex.com/prnewswire/innovent-to-present-at-41st-annual-j-p-morgan-healthcare-conference-2/ 2023-01-05T14:12:12+00:00 https://medicaex.com/prnewswire/iherb-top-wellness-trends-in-2023/ 2023-01-05T14:12:07+00:00 https://medicaex.com/prnewswire/fda-agrees-to-actinogen-six-month-phase-2b-alzheimers-disease-trial/ 2023-01-05T12:12:20+00:00 https://medicaex.com/prnewswire/yunji-successfully-concludes-its-new-year-festive-goods-shopping-festival/ 2023-01-05T12:12:05+00:00 https://medicaex.com/prnewswire/so-young-regains-compliance-with-nasdaq-minimum-bid-price-requirement/ 2023-01-05T11:12:07+00:00 https://medicaex.com/prnewswire/shine-on-biomedical-co-ltd-accorded-the-international-innovation-awards-2022-for-troy-car-exos/ 2023-01-05T11:12:07+00:00 https://medicaex.com/prnewswire/oneness-biotech-co-ltd-s-fespixon-honored-at-the-international-innovation-awards-2022/ 2023-01-05T10:12:08+00:00 https://medicaex.com/prnewswire/ubitus-and-smart-surgery-enable-doctors-to-practice-robotic-surgery-with-vr-streaming/ 2023-01-05T09:12:19+00:00 https://medicaex.com/prnewswire/oncusp-therapeutics-announces-appointment-of-robert-forrester-and-chau-khuong-to-board-of-directors/ 2023-01-05T09:12:14+00:00 https://medicaex.com/prnewswire/new-stic-trial-data-shows-longer-overall-survival-for-therapy-selection-based-on-cellsearch-ctc-count-in-patients-with-metastatic-breast-cancer/ 2023-01-05T07:12:14+00:00 https://medicaex.com/prnewswire/waterdrop-and-jemincare-collaborate-on-the-digital-service-platform-for-ckd-patients/ 2023-01-05T07:12:10+00:00 https://medicaex.com/prnewswire/sihuan-pharmaceutical%ef%bc%880460-hk%ef%bc%89-huisheng-biopharmaceutical-successfully-completed-the-a-round-of-financing/ 2023-01-05T01:12:13+00:00 https://medicaex.com/prnewswire/wuxi-biologics-and-gsk-enter-into-license-agreement-on-multiple-novel-bi-multi-specific-t-cell-engagers/ 2023-01-05T01:12:06+00:00 https://medicaex.com/prnewswire/pulnovo-medical-announces-dr-mingdong-zhang-former-fda-medical-device-officer-joins-scientific-advisory-board/ 2023-01-05T00:12:12+00:00 https://medicaex.com/prnewswire/cgtn-chinas-dynamic-zero-covid-policy-sets-the-foundation-for-reopening/ 2023-01-04T21:12:07+00:00 https://medicaex.com/prnewswire/china-to-downgrade-covid-19-management-to-class-b/ 2023-01-04T20:12:10+00:00 https://medicaex.com/prnewswire/heteros-nirmacom-is-worlds-first-generic-version-of-covid-19-oral-drug-paxlovid-to-receive-who-prequalification/ 2023-01-04T20:12:10+00:00 https://medicaex.com/prnewswire/transcenta-received-ind-clearance-from-nmpa-for-its-first-in-class-gremlin1-targeting-antibody-tst003-for-the-treatment-of-solid-tumors/ 2023-01-04T16:12:11+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-to-participate-in-the-sachs-associates-6th-annual-neuroscience-innovation-forum/ 2023-01-04T16:12:11+00:00 https://medicaex.com/prnewswire/nuralogix-announces-holy-grail-of-blood-pressure-measurement/ 2023-01-04T15:12:06+00:00 https://medicaex.com/prnewswire/img-welcomes-scott-ackerman-as-chief-commercial-officer/ 2023-01-04T15:12:06+00:00 https://medicaex.com/prnewswire/alphyn-biologics-reports-positive-results-from-first-cohort-of-phase-2a-trial-of-mild-to-moderate-atopic-dermatitis-treatment/ 2023-01-04T13:12:20+00:00 https://medicaex.com/prnewswire/p3-research-secures-investment-from-genesis-capital-to-accelerate-expansion/ 2023-01-04T13:12:20+00:00 https://medicaex.com/prnewswire/i-peace-inc-honored-in-biospectrum-asia-excellence-award-2022-with-special-recognition-in-cell-therapy/ 2023-01-04T13:12:18+00:00 https://medicaex.com/prnewswire/stemirna-receives-emergency-use-authorization-from-laos-for-its-proprietary-mrna-vaccine/ 2023-01-04T13:12:15+00:00 https://medicaex.com/prnewswire/sisram-medical-to-present-virtually-at-the-25th-annual-needham-growth-conference/ 2023-01-04T13:12:13+00:00 https://medicaex.com/prnewswire/call-for-application-for-2023-tsinghua-amgen-scholars-program/ 2023-01-04T13:12:13+00:00